Simplify complex regulatory, medical, and market workflows with AI-powered literature reviews and large document intelligence.
As AI continues to reshape industries, the pharmaceutical and biotech sectors are at the forefront of this transformation. OneRay, a bespoke, private generative AI solution, is designed to accelerate knowledge work, enhance compliance, and drive smarter decision-making in a secure, industry-specific environment.
OneRay isn’t just about automation — it’s about augmenting human potential with AI-powered insights, ensuring traceable, validated, and compliant outputs for medical, commercial, regulatory, quality, legal and market access teams.
Unlike generic AI solutions, OneRay has been co-created with pharma companies since early 2023 and has continuously evolved to meet industry needs. Now in its 4th generation, OneRay delivers cutting-edge AI capabilities tailored specifically for life sciences:
Unlike generic AI that requires retrofitting for pharma compliance needs, OneRay.ai is co-created with over 20 pharma companies and pre-trained on pharmaceutical data, medical terminology, and regulatory frameworks, providing sentence-level source referencing, validated pharma data sources, and native connections to Veeva and specialized medical databases.
OneRay.ai provides deep referencing with unlimited reference points per document, multiple reference points with details on accuracy and AI reasoning, and highlights the specific content used for generation, offering complete transparency and traceability for regulatory compliance.
OneRay.ai is a precision AI solution for life sciences built from the ground up for Pharma, Biotech, and Medtech companies, offering pharmaceutical-grade security with a private, single-tenant environment and pre-trained agents specifically designed for medical and regulatory workflows.
Organizations can achieve ROI within the first SLR deliverable, break-even after 30 material reviews for MLR use cases, or within the first two onboarding cycles for training agents, with most implementations delivering results within weeks rather than months.
OneRay.ai provides a growing set of pre-trained agents including summary, comparison, chat, validator, quiz, tutor, field companion, insights, next best action, talking head for HCP engagement simulations, dossier writing, systematic literature review, protocol and CSR agents, and competitor scanners.
Veeva is partnering with FFI to integrate advanced AI capabilities and combining cutting-edge AI expertise with deep life sciences domain knowledge to help pharmaceutical and biotech companies accelerate product development, enhance market strategies, and optimize customer engagement.
Our AWS partnership ensures enterprise-grade security, compliance with healthcare regulations, and seamless integration capabilities that enable rapid deployment and reliable performance across global pharmaceutical operations.
The none-exclusive partnership with Anthropic ensures access to state-of-the-art language models that demonstrate exceptional accuracy in scientific contexts while maintaining the highest standards of AI safety and ethical deployment.
OneRay isn’t just about AI innovation — it’s about tangible business impact, real value creation, and a clear return on investment (ROI). Our AI-powered solutions drive efficiency, compliance, and smarter decision-making across pharma and biotech organizations.
With OneRay, organizations accelerate AI adoption with clear, measurable outcomes. Whether reducing time-to-market, increasing compliance efficiency, or optimizing workflows, our AI-powered solutions are built to deliver impact from day one.
Develop content tailored to different target audiences and styles based on a curated list of content (papers, abstracts, books, white papers) and plain language instructions
Scan abstracts or pdf for a therapy area, summarize the key publications, incorporating scientific concepts
Life-science teams are under pressure to deliver systematic literature reviews (SLRs) and dossier content faster, with higher consistency and full traceability. Publication volumes keep...
As life sciences organizations allocate H2 2025 and 2026 budgets, the question isn't whether to invest in generative AI - it's how to implement it strategically for maximum impact.The...
Connect with our experts to explore how OneRay.AI can create measurable value across your specific workflows and challenges. During our personalized consultation, we’ll identify opportunities where our specialized AI solutions can accelerate your research, streamline critical processes, and enhance decision-making capabilities.
OneRay.ai is a precision AI solution for life sciences built from the ground up for Pharma, Biotech, and Medtech companies, offering pharmaceutical-grade security with a private, single-tenant environment and pre-trained agents specifically designed for medical and regulatory workflows.
The most implemented use cases include systematic literature reviews (reducing time from 38 to 8 weeks), field companion tools for MSL knowledge management, MLR reviewer agents (reducing review time by 60%), tutor and training agents with quizzing capabilities, publication summarization and processing, scientific data extraction for HCP conversation prep, KOL presentation analyzers for congress insights, and dossier builders for HTA and regulatory submissions.
OneRay.ai provides a single-tenant, ringfenced environment with zero data sharing to AI platforms, pharma-specific compliance with thorough IT risk assessments completed and deployment-ready infrastructure, ensuring all data remains private and secure.
OneRay.ai minimizes hallucinations through sentence-level source referencing with AI rationale for every output, validated pharma data sources, and a sophisticated referencing engine that provides accuracy scoring and highlights the exact content used for AI generation.
OneRay.ai offers native connections to Veeva Vault with advanced API integration, Distiller, specialized medical databases, and can connect to various approved data sources while maintaining pharmaceutical-grade compliance and security standards.
OneRay.ai provides a growing set of pre-trained agents including summary, comparison, chat, validator, quiz, tutor, field companion, insights, next best action, talking head for HCP engagement simulations, dossier writing, systematic literature review, protocol and CSR agents, and competitor scanners.
The platform automatically selects the best agent based on user questions, deploying pre-trained agents for specific tasks that can work sequentially or collaboratively with different instructions, sources, and deliverables to ensure optimal results.
Yes, FFI-Ventures, the solution provider of OneRay.ai is a Veeva AI Partner with advanced optimizations including AI-assisted slide preview and content generation, efficient review processes for CLMR workflows, and simple data selection through Veeva APIs and connectors for seamless content validation.
OneRay.ai provides content-driven micro-learning and full learning curricula with interactive quiz agents, tutor capabilities with talking head avatars, referencing of relevant approved content from Veeva or publications, and the ability to create training videos and voice content for onboarding and continuous learning.
OneRay.ai fully automates SLR screening, extraction, and narrative report generation, reducing agency and internal effort from 38 weeks to 8 weeks while improving quality and audit-readiness through its precision AI engine and validated workflows.
OneRay.ai offers export functionalities in Word, PowerPoint, and PDF formats with automatic inclusion of confidentiality clauses, supporting the creation of dossiers, reports, dashboards, and training materials with professional formatting and complete referencing.
OneRay.ai is developed by FFI Ventures, a boutique consulting company with deep life sciences expertise, led by senior leaders with extensive backgrounds at companies like Roche, Takeda, Pfizer, Bayer, and Novartis, combining over 20 pharma partnerships to ensure the solution addresses real industry needs.
OneRay.ai empowers medical affairs with real-time knowledge management for MSLs, publication processing that cuts writer and agency spend, scientific data extraction for HCP call preparation, and congress presentation analysis that eliminates manual slide mining while improving interaction quality and evidence-based engagement.
The talking head feature creates AI-powered avatar presentations using approved materials and publications, supporting training, HCP simulations, and launch preparations with improved streaming, and downloadable MP4 format for flexible deployment across learning management systems.
FFI Ventures brings since end of the year 2022 generative AI implementation experience and seven years with traditional AI, having proven their methodology with over 20 pharmaceutical companies from use-case identification through organization-wide scale-up with measurable ROI.
OneRay.ai's dossier builder agent authors HTA and regulatory dossiers from templates and data sources, replacing third-party writing services, compressing timelines by over 50%, and improving consistency, quality, and potentially reducing time to market for submissions.
Contact Stefan Flueckiger for a consultation, product demo, or to discuss your specific life sciences challenges and opportunities.